Logo
x

Search

Subscribe Now

 osteoporosis

Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

  • July 3, 2024
Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

  • June 12, 2024
Fresenius Reports the US FDA’s BLA Acceptance of FKS518 (Biosimilar, Denosumab)

Fresenius Reports the US FDA’s BLA Acceptance of FKS518 (Biosimilar, Denosumab)

  • May 28, 2024
Shanghai Henlius and Organon Got EMA’s Validation for the MAA of HLX14 (Biosimilar, Prolia & Xgeva)

Shanghai Henlius and Organon Got EMA’s Validation for the MAA of HLX14 (Biosimilar, Prolia & Xgeva)

  • May 24, 2024
Sandoz Reports EC’s Approval of Wyost and Jubbonti (Biosimilars, Xgeva and Prolia)

Sandoz Reports EC’s Approval of Wyost and Jubbonti (Biosimilars, Xgeva and Prolia)

  • May 22, 2024
Henlius and Organon Report the P-III Study Results of HLX14 (Biosimilar, Denosumab)

Henlius and Organon Report the P-III Study Results of HLX14 (Biosimilar, Denosumab)

  • April 8, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.